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1. Summary
Brugada syndrome (BrS) is associated with ventricular tachycardia originating
particularly in the right ventricle (RV). We explore electrophysiological fea-
tures predisposing to such arrhythmic tendency and their possible RV
localization in a heterozygotic Scn5aþ/2 murine model. Nav1.5 mRNA and
protein expression were lower in Scn5aþ/2 than wild-type (WT), with a further
reduction in the RV compared with the left ventricle (LV). RVs showed higher
expression levels of Kv4.2, Kv4.3 and KChIP2 in both Scn5aþ/2 and WT. Action
potential upstroke velocity and maximum Na
þ current (INa) density were cor-
respondingly decreased in Scn5aþ/2, with a further reduction in the RV. The
voltage dependence of inactivation was shifted to more negative values in
Scn5aþ/2. These findings are predictive of a localized depolarization abnorm-
ality leading to slowed conduction. Persistent Na
þ current (IpNa) density was
decreased in a similar pattern to INa. RV transient outward current (Ito) density
was greater than LV in both WT and Scn5aþ/2, and had larger time constants
of inactivation. These findings were also consistent with the observation that
AP durations were smallest in the RV of Scn5aþ/2, fulfilling predictions
of an increased heterogeneity of repolarization as an additional possible
electrophysiological mechanism for arrhythmogenesis in BrS.
& 2012 The Authors. Published by the Royal Society under the terms of the Creative Commons Attribution
License http://creativecommons.org/licenses/by/3.0/, which permits unrestricted use, provided the original
author and source are credited.2. Introduction
Brugada syndrome is characterized by increased clinical risks
of ventricular tachycardia (VT). It has been associated with a
loss of Na
þ channel function. Clinical studies suggest that BrS
is an RV disease resulting in an electrocardiographic, right
precordial, ST elevation, right bundle branch block and
changes specific to RV epicardial AP waveforms [1]. A
range of mechanisms may contribute to this arrhythmic phe-
notype. In addition to potential contributions from fibrotic
change and reduced connexin expression [2], electrophysio-
logical abnormalities could result in either abnormal
depolarization [3] or repolarization [4]. For example, reduced
INa could decrease conduction velocity. Abnormal Na
þ
expression and function may also affect action potential
(AP) duration: while the transient Na
þ current inactivates
within a few milliseconds, a slowly inactivating component,
IpNa,couldpotentiallyplayanimportantroleinAPrepolariza-
tion [5]. Although small, its persistence over the time course of
an AP could transfer quantities of charge comparable with
those carried by the transient current [5]. Finally, repolariza-
tion abnormalities could also result from reductions in the
IpNa relative to the early repolarizing Ito, with or without
accompanying changes in Ito.
The present study tests a prediction that one or more
of the latter electrophysiological abnormalities might be pre-
ferentially localized to the RV at the cellular and molecular
level, and thereby give rise to the arrhythmic phenotype
seen at the clinical or whole heart level. It thus explores for
preferential alterations in INa and IK expression in the RV in
a murine heterozygotic Scn5aþ/2 model for BrS. Previous
studies have either relied on largely non-invasive exper-
iments in humans or on a canine pharmacological wedge
preparationinwhichtheBrSphenotypewasreplicatedbymul-
tiple pharmacological interventions. In contrast, although BrS
is a genetically heterogeneous condition, up to 30 per cent of
patients have mutations in the SCN5A gene [6]. Thus far, it
is the only gene that has been extensively studied in
connection with BrS. Furthermore, the mouse model closely
reproduces many of the key human features of BrS, including
ST elevation [7], and both slowed conduction and repolariza-
tion heterogeneities leading to ventricular arrhythmogenesis
originating in the RV, as demonstrated in mapping exper-
iments [8]. It also shows the complex range of further
phenotypes that include sick sinus syndrome and progressive
conduction disorders associated with the clinical SCN5A
gene modification [9]. Finally, Scn5aþ/2 hearts show fibrosis
and reduced connexin expression that worsens with age [2],
in line with similar clinical findings [10]. This appears to
affect the RV to a greater extent than the LV, leading to a
greater degree of conduction slowing in the RV and
thus possibly contributing to the predisposition of the RV
to re-entrant arrhythmias [3].
However, despite a detailed description of the electro-
physiological abnormalities in the Scn5aþ/2 mice, so far no
direct link has been made between the loss of Na
þ channel
function and the predilection for arrhythmias to be initiated
in the RV. The only proved effective treatment of BrS so far
is an implantable cardioverter–defibrillator, which is limited
by low appropriate shock rates and device-related compli-
cations [11]. Further clarification of the relationship between
arrhythmias and their basis in ion channel properties and
localization could prove crucial in planning possible new
pharmacological therapies for BrS. The present experiments
investigate the relative expression and function of Na
þ and
K
þ channels in the LV and RV of WT and Scn5aþ/2
hearts for the first time, and hence assess their contributions
to conduction slowing and repolarization heterogeneities in
the arrhythmogenic mechanism of BrS.
3. Methods
3.1. Experimental animals
Mice aged three to five months were obtained from breeding
pairs of heterozygote Scn5aþ/2 and WT inbred 129/sv
mice. Hearts from all groups were subject to iden-
tical experimental procedures, permitting their comparison.
WT mice were initially supplied by Harlan (UK), and
Scn5aþ/2 mice were originally generated from these as
described previously [12]. Mice were killed by cervical dis-
location, in compliance with the UK Animals (Scientific
Procedures) Act 1986. The investigation conforms to the
Guide for the Care and Use of Laboratory Animals and
was performed under licences approved by local ethical com-
mittees and issued by the UK Home Office.
3.2. Real time reverse transcriptase-PCR
To quantify changes in the mRNA expression levels of Na
þ
channel a-subunits and a range of K
þ channels in murine
hearts, real time reverse transcriptase-PCR (RT-PCR) exper-
iments were performed on an ABI 7500 Fast Cycler (Applied
Biosystems, Warrington, UK). Total RNA was isolated from
the LV and RV of WT and Scn5aþ/2 mice (n ¼ 4e a c h )
using a Qiagen RNAeasy kit. Excised tissues were stored in
RNAlater (Ambion, Warrington, UK) to maintain the integrity
of the RNA before isolation. The total RNA was reverse tran-
scribed into cDNA using random hexamer primers and a
SuperScript III kit (Invitrogen, Paisley, UK). Oligos for Scn5a
were fluorescein amidite (FAM) labelled (Applied Biosystems).
All experiments were performed in duplicate.
The number of copies of mRNA was calculated from
its respective threshold cycle (CT) using a standard curve.
The 2
2DDCT method [13] was used to calculate gene expression
relative to the expression of the housekeeper gene, glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH). These values
were then normalized to the mean Nav1.5 gene expression in
the LV of the WT mice.
3.3. Western blots
Hearts were excised and placed in ice-cold Krebs–Henseleit
buffer containing: 119 mM NaCl, 25mM NaHCO3,4 m M
KCl, 1.2mM KH2PO4, 1mM MgCl2, 1.8mM CaCl2,1 0 m M
glucose and 2 mM sodium pyruvate (pH 7.4). The ventricles
were removed and the LV and RV free walls were isolated
and flash-frozen. The tissues were ground in liquid nitrogen
with a pestle and mortar. They were then homogenized using
a Dounce homogenizer (Jencons, Lutterworth, UK) in ice-
cold lysis buffer containing: 50 mM Tris pH 8.0, 150 mM
NaCl, 1 per cent NP40, 0.2 per cent SDS, 0.5 per cent Na
Deoxycholate, 1 mM EDTA and complete protease inhibitor
cocktail (Roche, Burgess Hill, UK), and rotated for 1 h at
48C. The samples were then centrifuged at 2000g for 10 min
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2and the supernatant kept. The pellet was resuspended in lysis
buffer and recentrifuged at 2000g for a further 10 min, and the
second supernatant added to the first. The combined super-
natants were then ultracentrifuged at 100 000g for 1 h, and
the pellet suspended in buffer containing: 4 mM HEPES,
320 mM sucrose and complete protease inhibitor cocktail.
The protein concentration of each sample was established
using a Pierce bicinchoninic acid assay kit (Thermo Scientific,
Rockford, USA), using microplate assays in triplicate.
All equipment and consumables mentioned in this para-
graph are from Invitrogen unless otherwise stated. Protein
samples were mixed with 4x NuPAGE LDS sample buffer,
10x b-mercaptoethanol and H2O ,a n dw e r eh e a t e da t7 0 8C
for 10 min. XCell SureLock Mini-Cells were used to run gel
electrophoresis. One of two sets of electrophoresis conditions
were used depending on whether the protein to be analysed
w a so fh i g ho rl o wm o l e c u l a rw e i g h t .F o rh i g hm o l e c u l a r
weight proteins, electrophoresis was carried out using
NuPAGE Novex 3 to 8 per cent Tris-Acetate gels at 30 V for
90 min, and then at 140 V overnight at 48Cw i t hN u P A G E
Tris-Acetate running buffer and NuPAGE antioxidant, along-
side a Hi-Mark pre-stained high-molecular-weight protein
standard. For low-molecular-weight proteins, electrophoresis
was carried out using NuPAGE Novex 4 to 12 per cent
Bis-Tris gels at 140 V for 2 h with NuPAGE MES SDS running
buffer and NuPAGE antioxidant, alongside a pre-stained
protein standard. TwentymM of total protein was loaded in
each lane. Protein bands were transferred onto polyvinylidene
difluoride (PVDF) membranes by an XCell II Blot Module, with
NuPAGE transfer buffer, 10 per cent methanol and NuPAGE
antioxidant, at 100 mA overnight at 48C. Membranes were
blocked for 5 h in 5 per cent BSA-phosphate-buffered saline
(PBS)—1 per cent Tween, prior to overnight incubation at 48C
with primary antibody. Antibodies used were to Nav1.5
(1:500, ASC005, Caltag Medisystems, Alomone, Israel), and
Kv1.5, Kv4.2, Kv4.3, Kir2.1, Kv1.4 and KChIP2 (1:1000, Abcam,
UK). The membranes were incubated for 1 h at room tempera-
ture with secondary antibody conjugated with horseradish
peroxidase from Sigma-Aldrich (Poole, Dorset, UK). Western
blot development was performed with Amersham ECL-plus
reagents (Amersham Biosciences, Amersham, UK).
To confirm equal protein loading, the PVDF membranes
were stripped by incubation in stripping buffer (200 mM
glycine, 1% SDS, 1% Tween, adjusted to pH 2.2) and then
rinsed first with PBS and then with PBS-1 per cent Tween.
The membranes were then reblocked, and incubated over-
night with antibody to either heavy chain cardiac myosin
(1:200, ab50967, Abcam, Cambridge, UK) for high-molecular
weight-proteins, or to GAPDH (1:5000, ab9482, Abcam)
for low-molecular-weight proteins. Secondary antibody incu-
bation and detection were carried out as above. Radiographs
were scanned and areas of interest cropped. Band intensity
was calculated using IMAGEJ (NIH, Bethesda, USA), and
plots drawn of protein expression normalized to either
heavy chain myosin or GAPDH expression.
3.4. Ventricular myocyte isolation
Myocytes were isolated as previously described [14]. Mouse
hearts were rapidly removed and placed in ice-cold normal
Tyrode (NT) solution containing: 140 mM NaCl, 6mM KCl,
1mM MgCl2, 1 mM CaCl2, 10 mM glucose, 10 mM HEPES,
pH adjusted to 7.4 with 2 M NaOH. The ascending aorta
was cannulated with a blunted 21 g needle. The heart was
then retrogradely perfused for 2–3 min at 378C with NT sol-
ution followed by a further 5 min in low Ca
2þ (LC) solution
containing: 120 mM NaCl, 5.4mM KCl, 5mM MgSO4, 0.045
mM CaCl2, 5mM sodium pyruvate, 20mM glucose, 20mM
taurine, 10 mM HEPES, 5mM nitrilotriacetic acid, bubbled
with 100% O2; pH 6.96. The solution was changed to an
enzyme solution (ES) containing: 120 mM NaCl, 5.4mM
KCl, 5mM MgSO4, 0.2mM CaCl2, 5mM sodium pyruvate,
20mM glucose, 20mM taurine, 10mM HEPES, bubbled
with 100% O2; pH 7.4 with addition of protease (4 U ml
21,
Sigma) for 1 min, followed by perfusion for 8 min with ES
solution containing collagenase (0.8 mg ml
21; Worthington)
and hyaluronidase (0.5 mg ml
21, Sigma). At this stage, the
heart was swollen and flaccid but with anatomy still intact.
The free walls of the LV and RV were then separated and
cut into small pieces using a scalpel blade. The tissue was
then agitated for a further 5 min in ES solution. This suspen-
sion was gently triturated using a pipette, filtered and
resuspended in ES solution. Myocytes were stored in ES sol-
ution at room temperature and used within 7–8 h of
isolation. Isolated myocytes were checked under a light
microscope to confirm cell integrity. Live myocytes appeared
as smooth and rod-shaped cells.
3.5. Electrophysiology measurements
3.5.1. Measurement of action potentials
Cells were superfused with NT solution at 378Ca n ds t u d i e d
using a perforated patch technique using an Axon 2B amplifier
(Axon Instruments, CA, USA). The pipette resistance was 1–
2M V, and the pipette-filling solution contained: 125mM
KCH3O3S, 20 mM KCl, 10mM NaCl, 10 mM HEPES, 5 mM
MgCl2, pH 7.2 with KOH, plus amphotericin-B (final concen-
tration 240 mgm l
21). APs were measured in current-clamp
mode after stimulation at 1, 3 and 5 Hz using a 1 ms, 1.2–
1.4 nA pulse. The APs measured were analysed using PCLAMP
v. 10 software (Molecular Devices, USA), and averaged over
30 consecutive beats. Traces were then averaged with reference
to the stimulation signal, and times to 50 per cent (APD50), 70
per cent (APD70) and 90 per cent repolarization (APD90)w e r e
taken as a measure of the AP duration for comparison between
groups. Maximum upstroke velocity was measured as the
maximum gradient of the upstroke of the AP waveform.
3.5.2. Current density measurements
Forall current density measurements, thewhole-cell configur-
ation of the patch-clamping technique was employed using a
Multiclamp 700A amplifier (Molecular Devices). Borosilicate
glass pipettes (0.86 mm outer diameter; Harvard Apparatus,
Kent, UK) were used, with a resistance of 1.5–2.5 MV. All
the experiments were performed at 378C, apart from those
measuring the fast Na
þ current, which were performed at a
constant room temperature of 228C. The rate of superfusion
was 2–3 ml min
21. Miniature solenoid valves (The Lee
Company, Essex, UK) were used to produce fast changes
in superfusate. All the recordings were done after 3 min of
membrane rupture, after which time pilot experiments
demonstrated stable voltage dependency of currents. Each
set of measurements took approximately 5 min to complete.
Capacitance and 80 to 90 per cent series resistance
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3compensation was performed prior to each recording. Only
cells with initial resting potentials between 270 and
280 mV, initial seal resistances greater than 5 GV with
stable residual series resistances less than 1 MV, and low leak-
age currents (less than 0.1 nA at 2120 mV) were studied. Cell
stability in the course of the experiments was further followed
by comparing transients from the same (largest) voltage steps
at successive times during the protocol.
The currents obtained were filtered at a 10 kHz high–
frequency cut-off (four pole Bessel filter) and digitized at
100 kHz using PCLAMP software.
The membrane capacitance (in picofarad) of each cell was
initially measured by integrating the area under a capacita-
tive transient induced by a 10 mV hyperpolarizing clamp
step (from 280 to 290 mV) and dividing this area by the
voltage step. There were no significant differences in mean
cell capacitance between groups (122.4+6p Fi nW TL V ,
119.5+7 pF in WT RV, 129.3+6p Fi nScn5aþ/2 LV and
126.6+9p Fi nScn5aþ/2 RV; n ¼ 36; p . 0.05). All the
currents were then normalized to the whole-cell capacitance
for cross-group comparisons.
3.6. Na
þ current, INa
The fast Na
þ current INa was measured using a technique
previously described [15]. Pipettes were filled with: 70.26 mM
CsCl, 24.74mM Cs-aspartate, 10 mM HEPES, 1 mM Na2ATP,
4mMMgATP,1.37mMMgCl2and10 mMCs-BAPTA,adjusted
topH7.2using CsOH.Cells wereinitiallyperfusedwithNTsol-
ution containing 200 mMC d
2þ. To achieve optimum voltage
control, Na
þ currents were recorded in a low [Na
þ]s o l u t i o n .
This solution contained: 10mM NaCl, 140mM CsCl, 10mM
glucose,10mMHEPES,1mMMgCl2and1mMCaCl2,adjus ted
to pH 7.4 using CsOH. Na
þ currents were initially measured
before and after perfusion with 10 mMt e t r o d o t o x i n( T T X ) ,a n d
the TTX sensitive current calculated; however, pilot studies
showedthatunderourexperimentalconditions,TTXeliminated
the whole current being studied, and therefore showed that we
were specifically recording the Na
þ current before addition of
TTX (figure 4). Capacitance subtraction was not performed
and thus recordings demonstrated an initial spike; however,
this was fast enough not to interfere with the subsequent Na
þ
current and the pilot studies using TTX subtraction eliminated
the spike, thus demonstrating that it was due entirely to the
capacitative transient.
The currents obtained were filtered at a 10 kHz high-fre-
quency cut off and digitized at 100 kHz using PCLAMP
software. In each experiment, the series resistance was com-
pensated by 80 to 90 per cent and each protocol used a
holding potential of 2120 mV. The equilibrium potential
for Na
þ was calculated from the Nernst equation to be
þ40 mV, which was confirmed through initial experiments
recording voltage steps to this level. For fast Na
þ current
recordings, the mean values of residual series resistance
after 80 to 90 per cent compensation were 0.53+0.1 MV
for WT LV, 0.49+0.1 MV for WT RV, 0.64+0.1 MV for
Scn5aþ/2 LV and 0.67+0.1 MV for Scn5aþ/2 RV. The cur-
rent required to keep the cells at holding potential was 0.2+
0.01 nA, resulting in a voltage error at the holding potential
less than 0.1 mV. The peak values of current flowing during
the voltage steps were 5.4+0.1 nA for WT LV, 5.3+0.1 nA
for WT RV, 4.1+0.1 nA for Scn5aþ/2 LV and 2.7+
0.1 nA for Scn5aþ/2 RV. Thus, peak voltage error resulting
from residual series resistance was 2.9+0.1 mV for WT LV,
2.6+0.1 mV for WT RV, 2.6+0.1 mV for Scn5aþ/2 LV
and 1.8+0.1 mV for Scn5aþ/2 RV. If experiments demon-
strated evidence of inadequate voltage control (e.g. a
‘threshold phenomenon’ near the voltage range for Na
þ
channel activation) data were discarded. The absence of
crossover of the current traces as the current magnitude
was changed and the shape of the current–voltage (I–V)
relationship remaining unchanged for difference peak current
values further suggest adequate voltage control [16,17].
First, the voltage dependence of activation was studied by
applying depolarizing pulses of 250 ms duration over a series
of voltage steps from a fixed holding voltage of 2120 mV, in
5 mV increments, to þ20 mV. The peak current densities (pA/
pF) were calculated by dividing the peak currents amplitude
by Cm and the I–V relationship plotted. The values of peak
Na
þ conductance (gNa) were determined from the equation
gNa ¼
INa
Vm   ENa
;
asfirstdescribedbyHodgkinetal.[18]asalinearapproximation
of the Goldman–Hodgkin–Katz equation and subsequently
used extensively in patch clamp analysis of cardiac myocytes
[15,19–21], where INa is the peak current density and the ENa
is the [Na
þ] reversal potential. The gNa values calculated from
each myocyte were normalized against the corresponding
peak gNa value. When plotted against the test-pulse voltage,
the data assumed a sigmoid function, increasing with mem-
brane potential.
The voltage dependence of steady-state inactivation was
also examined using conditioning pre-pulses of 500 ms dur-
ation. These variable pre-pulses were applied over a voltage
range from 2140 to 230 in 5 mV increments. Each pre-
pulse was followed by a constant test pulse to 220 mV at a
duration of 20 ms. Normalized currents were then plotted
against the pre-pulse voltage. The data assumed a sigmoid
function, decreasing with membrane potential. Both inacti-
vation and activation data were fitted with a single
Boltzmann function, as used extensively in previous studies
[15,20–24], of the form:
y ¼ 1 þ exp
sðVm   V1=2Þ
k
   1
:
For activation curves, the y-values correspond to the
normalized conductance values and constant s equals 21.
For inactivation curves, the y-values correspond to the nor-
malized current values and constant s equals þ1. This
yields the half-maximal voltage (V1/2) and exponential
slope factor (k) values.
3.6.1. Persistent Na
þ current
The persistent Na
þ current (IpNa) was measured using a tech-
nique previously described [25]. Cells were superfused at
378C with modified NT solution, with K
þ substituted with
Cs
þ, and containing 10 mM nifedipine (Sigma, Poole, UK),
100 mM strophantidin (Sigma) and 30 mM niflumic acid
(Sigma). The pipette filling solution contained: 115mM Cs-
aspartate, 20mM TEA-Cl, 10mM EGTA, 10mM HEPES,
5mM MgATP, pH 7.2. From a holding potential of 2100 mV,
increasing voltage (20 mV) steps from 280 mV to þ20 mV
for 1 s were applied with a cycle length of 5 s. The protocol
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4was repeated in the presence of 20 mM TTX (Alomone Labs.,
Israel), and the TTX-sensitive current was analysed. IpNa den-
sity was taken as the average current between 30 and 80 ms
after depolarization and normalized to cell capacitance. This
period was chosen because this is approximately the range of
APDs measured in our experiments.
3.6.2. Transient outward current, Ito
The transient outward current Ito was measured using a
technique previously described [26]. Cells were superfused
with NT solution containing 200 mMC d
2þ and the pipette-
filling solution contained: 120 mM K-glutamate, 10mM
KCl, 2mM MgCl2, 10 mM HEPES, 5mM EGTA, 2mM
Mg-ATP, pH 7.2 with KOH at 378C. Pipette resistance was
1.5–2.5 MV. Ito was elicited by increasing voltage steps (1 s
duration) from 240 mV to þ70 mV with a cycle length of
5 s in increments of 10 mV. In these studies, the transient out-
ward current was separated from the other currents by the
following procedures. The holding potential was held at
240 mV to inactivate the sodium current. ICa was largely
blocked by 0.2 mM CdCl2 included in the recording solution.
EGTA was included in the pipette solution to minimize Ca
2þ-
induced inactivation. Ito was taken as the peak of the transient
outward current Ito,peak from which the steady-state current
Iss had been subtracted. While IKs may also demonstrate
inactivation, studies have shown that this plays a relatively
minor role in repolarization in the murine ventricle [27,28].
As for INa, the I–V relationship was plotted, as well as the
voltage dependence of activation as determined from con-
ductance calculations, and fitted with a single Boltzmann
distribution. The time course of inactivation of the decay
phase of the transient outward current was best fit by a
double exponential decay function in the following form:
Itotal ¼ Ifast exp
 t
tfast

þ Islow exp
 t
tslow

þ I1;
The two time constants were plotted as a function of
voltage. Steady-state inactivation parameters of Ito,peak were
obtained with a double-pulse protocol using 1 s prepulses
to voltages from 2100 to þ20 mV from a holding potential
of 2100 mV. Peak currents at the test pulse to þ40 mV
were normalized to the maximal transient outward cur-
rent elicited by the test pulse and fitted by a single
Boltzmann distribution.
3.7. Statistical procedures
Patch clamp measurements were made from a set of 8 WT
and 8 Scn5aþ/2 mice, with n numbers representing the
total number of cells studied. 4 WT and 4 Scn5aþ/2 mice
were each used for RT-PCR experiments and a further four
each for Western blot experiments. All electrophysiological
parameters and expression levels of protein and mRNA
were expressed as mean+s.e.m. values. Their significant
differences were analysed using ANOVA applied to all
groups with post-hoc Tukey’s honestly significant difference
tests then applied to paired groups. A p-value of less than
0.05 was the criterion for significance.
4. Results
4.1. Real-time reverse transcriptase-PCR
Nav1.5 mRNA expression was significantly lower in
Scn5aþ/2 hearts than in WT, as previously reported [22]
(figure 1). While this was true in both the LV and RV, there
was a bigger drop in the RV. While in the LV expression
fell to approximately two-thirds of that in the WT, in the
RV it fell to about one-third of that in the WT. Interestingly,
in the WT there was significantly higher expression of
Nav1.5 mRNA in the RV than LV, while in the Scn5aþ/2
hearts, there was no significant difference between mRNA
expression in the two ventricles.
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Figure 1. mRNA expression patterns. Graph of mRNA expression in Na
þ and K
þ channels in the LV (bars with stripes) and RV (grey bars) of WT and Scn5aþ/2
hearts. Values are given relative to Nav1.5 mRNA expression in LV WT hearts. Significant differences: asterisks (*), effect of genotype; hashes (#), effect of cardiac
ventricle (n ¼ 4 for each group).
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5Regarding mRNA expression for K
þ channels in the
heart, we found no significant differences either between
LV and RV, or between WT and Scn5aþ/2 hearts for
Kir2.1, Kv1.4 and Kv1.5. However, there were significantly
higher mRNA expression levels of Kv4.2 in RVs in both
WT and Scn5aþ/2 hearts, although there was no difference
between WT and Scn5aþ/2.K v4.3 showed a small increase
in WT RV compared with the WT LV or Scn5aþ/2
RV, but there were no differences between LV WT or
Scn5aþ/2, nor between LV and RV Scn5aþ/2. Lastly,
there was higher mRNA expression of KChIP2 in WT than
Scn5aþ/2 RV, and in the RV than LV, of both WT
and Scn5aþ/2 hearts.
4.2. Western blots
Western blots of Nav1.5 demonstrated a single band at
around 220 kDa (predicted weight 227 kDa; figure 2a).
There was no significant difference in the Nav1.5 expression
found between the LV and RV of WT hearts (figure 2b).
As expected, Scn5aþ/2 hearts had significantly reduced
Nav1.5 expression, but there was a further difference between
LV and RV, with approximately 30 per cent reduction in the
LV and approximately 50 per cent reduction in the RV when
compared with WT, resulting in a significantly lower
expression of Nav1.5 in the RV compared with the LV of
Scn5aþ/2 hearts. For K
þ channels, there were no significant
differences in protein expression either between LV and RV
or WT and Scn5aþ/2 hearts for Kir2.1, Kv1.4 or Kv1.5
(figure 2c,d). However, there were significantly higher protein
levels in the RV than LV for both WT and Scn5aþ/2 hearts
for Kv4.2, Kv4.3 and KChIP2, with no difference between WT
and Scn5aþ/2.
4.3. Electrophysiology
APDs and INa, IpNa and Ito densities were measured using
patch clamp techniques. APs from all groups demonstrated
a triangular AP morphology, with a resting membrane poten-
tial of around 270 mV and with an overshoot to around
þ40 mV, in agreement with previous studies in WT mice [29].
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64.4. Scn5aþ/2 right ventricle action potentials have
shorter durations and lower maximum upstroke
velocities compared with respective left ventricles
and with wild-type
The maximum upstroke velocity (dV/dtmax) of the APs,
measured as the maximum gradient of the AP upstroke, can
be used to give an indication of Na
þ channel function [30].
dV/dtmax was reduced in Scn5aþ/2 hearts compared with
WT in both LV and RV myocytes at all pacing frequencies
(figure3).ThedV/dtmaxvalueswerenotsignificantlydifferent
between LV and RV in WT myocytes, but were significantly
reduced in RV compared with LV in Scn5aþ/2 myocytes.
There were no significant differences overall in the amplitude
of the APs between any group.
At all three pacing frequencies, APD90 was significantly
lower in the RV compared with the LV of Scn5aþ/2 myo-
cytes, but not in WT. The APD90 of RV Scn5aþ/2
myocytes was also significantly less than that of RV WT myo-
cytes, while there were no differences between the respective
LVs. Similar results were obtained for the APD70 measure-
ments. These myocyte data correlate well with previous
studies from APD recordings using monophasic AP electro-
des in Langendorff perfused hearts [31].
4.5. Scn5aþ/2 right ventricle myocytes have lower INa
than the respective left ventricle and in wild-type
Na
þ currents were initially measured before and after per-
fusion with 10 mM TTX, and the TTX-sensitive current
calculated; however, pilot studies showed that under our
experimental conditions, TTX eliminated the entire current
being studied, and therefore showed that we were specifically
recording the Na
þ current without the need for TTX subtrac-
tion (figure 4). There were no significant differences in mean
capacitance of myocytes between any of the groups.
Values of maximum Na
þ current density (INamax) from
WT myocytes were in agreement with those from previous
studies [23]. There were no significant differences in INamax
or I–V relationship between LV and RV myocytes from WT
hearts (figure 5a–c). INamax was significantly less in both LV
andRVofScn5aþ/2 heartsthan inWT;thiswasalsoreflected
indifferencesintheI–Vrelationship.Inaddition,inScn5aþ/2
hearts Na
þ current density was reduced in the RV compared
with the LV. Overall, INamax in the RV of Scn5aþ/2 hearts
was around 50 per cent that of RV WT, while in the
Scn5aþ/2 LV it was around 70 per cent of WT LV.
Activation curves yielded parameters of voltage depen-
dence of activation similar to previous studies [12,22,23].
There were no significant differences in these parameters
between any of the groups studied (figure 5d and table 1).
The inactivation curve was shifted to more negative values
in the Scn5aþ/2 hearts compared with WT for both RV
and LV, and for the RV was further shifted to more nega-
tive values than the LV in Scn5aþ/2 hearts (figure 5e and
table 1). Thus, the fraction of Na
þ channels available for car-
diac depolarization is smaller in the Scn5aþ/2 than WT, and
further reduced in the RV.
4.6. Lower IpNa in Scn5aþ/2 right ventricle myocytes
compared with respective left ventricle and with
wild-type
We proceeded to measure the persistent Na
þ current, IpNa.
Following a similar pattern to INa, maximum IpNa was
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8significantly smaller in Scn5aþ/2 than WT myocytes, and
while there was no difference in maximum IpNa between
WT LV and RV, it was significantly smaller in the RV of
Scn5aþ/2 hearts than LV (figure 6).
4.7. Higher Ito in right ventricle than left ventricle of
wild-type and Scn5aþ/2 myocytes
Lastly, we measured inactivating K
þ current by subtracting
the sustained current Iss from the point of depolarization
onwards in raw traces (figure 7a). The inactivating K
þ current
was taken to represent Ito max, as, while more slowly inacti-
vating K
þ currents do exist in the mouse ventricle, they are
relatively small [27]. There were no significant differences in
Iss amplitude between any of the groups. Itomax was signifi-
cantly greater in the RV than LV of both Scn5aþ/2 and WT,
which was also reflected in differences in the I–V relationship
(figure 7b,c). There were no significant differences in Itomax
or the I–V relationship between WT and Scn5aþ/2
myocytes from either LV or RV.
Analysis of the kinetics of inactivation through fitting to a
double exponential decay function demonstrated three com-
ponents of the K
þ current, which are likely to represent Ito,
IKs and Iss, respectively [32]. The amplitude of Ifast was
approximately 10 times that of Islow, supporting evidence
that Ito is the dominant inactivating K
þ current in the
mouse ventricle [27]. Figure 7d shows the time constants of
decay of the two inactivating components from myocytes
from all groups. There was no clear voltage dependence,
similar to findings in other studies [32].
The RV showed values of t(fast) and t(slow) that were
higher than their respective values in the LV in both the
WT and Scn5aþ/2. These time constants were then higher
in the Scn5aþ/2 than WT in the RV for all voltages for
t(fast) and at more positive voltages for t(slow). In contrast,
the LV of both WT and Scn5aþ/2 showed similar values
of t(fast) and t(slow).
Therewerenosignificant differencesinvoltagedependence
of activation (figure 7e and table 2). Voltage dependence of
inactivationwas shiftedto morenegativevaluesintheRVcom-
pared withLVofbothWTand Scn5aþ/2 hearts,buttherewas
a shift to more positive values for Scn5aþ/2 myocytes
compared with WT (figure 7f and table 2).
5. Discussion
These experiments use a Scn5aþ/2 murine model to test a
hypothesis that localizes potentially arrhythmogenic
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Table 1. Parameters of activation and inactivation from Boltzmann ﬁts (millivolts) to the curves produced from INa in myocytes from the LV and RV of WT and
Scn5aþ/2 hearts (n ¼ 17 for activation; n ¼ 12 for inactivation for each group).
activation inactivation
V1/2 kV 1/2 k
WT LV 258.88+2.85 3.65+0.66 274.64+1.83 7.95+0.62
WT RV 260.42+3.04 4.14+0.42 275.35+1.72 7.21+0.60
Scn5aþ/2 LV 264.61+2.96 3.44+0.78 284.16+1.53
a 6.56+0.71
Scn5aþ/2 RV 263.69+3.40 5.46+0.93 291.12+1.64
a,b 6.61+0.74
aSignificant effect of genotype.
bSignificant effect of cardiac ventricle.
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9electrophysiological mechanisms to the RV. This system
has previously been used to model BrS, and mapping
studies have demonstrated slowed conduction and
repolarization heterogeneities localized to the RV leading
to re-entrant polymorphic VT originating specifically in
the RV [3,8]. Our findings add to (i) reports associating the
Scn5aþ/2 mutation with reduced Na
þ current expres-
sion [12], and (ii) previous studies in WT mice that
demonstrated higher Scn5a mRNA and protein expression
and Na
þ channel availability in endocardium than
epicardium [33]. Neither study made comparisons between
RV and LV.
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Table 2. Parameters of activation and inactivation from Boltzmann ﬁts (millivolts), and the time constants of inactivation from the double exponential ﬁt to the
curves produced from Ito in myocytes from the LV and RV of WT and Scn5aþ/2 hearts (n ¼ 14 for each group).
activation inactivation
V1/2 kV 1/2 k
WT LV 211.06+2.54 14.26+3.24 242.72+1.86 9.18+1.10
WT RV 29.07+2.85 17.24+3.21 246.40+1.72
a 7.80+0.92
Scn5aþ/2 LV 29.58+3.20 14.15+3.95 237.13+0.91
b 11.30+0.70
Scn5aþ/2 RV 215.57+3.44 20.69+3.55 242.98+1.01
a,b 10.15+0.73
aSignificant effect of cardiac ventricle.
bSignificant effect of genotype.
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10Our comparisons have fulfilled the predictions of an elec-
trophysiological hypothesis involving a reduced INa
mechanism. Thus, while the patch-clamp experiments
demonstrated that WT myocytes possessed similar peak INa
magnitudes in the RV and LV, these were decreased in both
the RV and LV in the Scn5aþ/2, but with a greater reduction
in RV than LV. Yet Na
þ conductance activation curves were
indistinguishable. These findings were also compatible with
two underlying mechanisms acting upon Na
þ channel func-
tion. First, there could be differing Na
þ channel inactivation
properties in the RV and LV between the WT and the
Scn5aþ/2. Thus, although WT RV and LV showed similar
inactivation curves, both the RV and LV of the Scn5aþ/2
showed negative shifts in inactivation properties, with the
RV showing the greatest alterations. Second, the electro-
physiological results implicated reductions in expression of
otherwise normal Na
þ channels. Thus, the Na
þ current
reductions took place even at holding voltages at which
there was no significant inactivation. Furthermore, the cur-
rent reductions exactly paralleled the corresponding
patterns of protein expression, corroborating the latter mech-
anism. So did patterns of mRNA expression, apart from
suggesting a relative translational upregulation in the LV
relative to the RV Scn5aþ/2. These findings precisely corre-
lated with the outcomes of similar AP (dV/dt)max values in
the RV and LV in the WT, which were reduced in Scn5aþ/
2 to a greater extent in the RV than the LV.
Our studies also showed a reduction in IpNa in the RV of
Scn5aþ/2 hearts, which may well contribute to the shorter
APDs in this region. APD values were correspondingly
shorter in Scn5aþ/2 RV than WT RV and than Scn5aþ/2
LV. Other groups have reported a gradient of expression of
IpNa across the ventricular wall [5]. Although the physio-
logical significance in humans is still unclear, the IpNa
gradient is thought to be important in the pro- and anti-
arrhythmic effect of class 1 agents. This is the first study to
show heterogeneity of IpNa between ventricles in any
model, and to contribute to increased repolarization
heterogeneity.
Differential K
þ channel expression has also been impli-
cated in the arrhythmogenic mechanism in BrS. In murine
hearts, K
þ currents include the readily separable non-
inactivating Iss component. They also include inactivating
components—mainly the fast inactivating Ito and slow inacti-
vating IKs. These could be separated through their fast (t(fast))
and slow (t(slow)) time constants. As described on previous
occasions [27,28], IKs appeared to play a relatively minor
role in repolarization in the murine ventricle, giving a slow
current Islow whose magnitude was less than 10 per cent
that of the remaining Ifast. Thus, by far the greater part of
the outward current observed in the present experiments
appeared to arise from Ito.
Ito channels control a prominent repolarizing current, the
Ca
2þ-independent transient outward K
þ current [34]. While
in humans and large mammals, both fast (Ito,f) and slow
(Ito,s) channels are expressed throughout the heart, in the
mouse heart Ito,s is present only in the interventricular
septum, and thus the focus of this study is on Ito,f, for
which the molecular correlates are Kv4.3/Kv4.2 [35]. Ito,f has
thus been well documented to be expressed in a hetero-
geneous manner throughout the ventricles of mammalian
hearts, including mice, in concordance with known AP dur-
ations [32,36,37]. The present experiments demonstrated
larger peak Ito magnitudes in the RV than the LV. However,
there was no particular difference in this peak between
Scn5aþ/2 and the WT. Furthermore, there were no differ-
ences in the voltage dependence of activation of Ito in RV
or LV whether Scn5aþ/2 or WT. The voltage-dependence
of Ito was slightly shifted to more negative values in the RV
than the LV in both WT and Scn5aþ/2, which would poten-
tially reduce its repolarizing effect in parallel with a reduced
RV expression of INa. However, it was shifted to more posi-
tive values in Scn5aþ/2 than WT, which would accentuate
the imbalance between repolarizing and depolarizing cur-
rents. Furthermore, the RV showed slower inactivation
kinetics than did the LV in both WT and Scn5aþ/2, with a
further slowing in the Scn5aþ/2.
In line with previous studies in mixed ventricular lysates
[22], Kir2.1 (mediating the inward rectifier IK1), Kv1.4 (mediat-
ing Ito,s) and Kv1.5 (mediating IKs) demonstrated similar
mRNA and protein expression levels. In contrast, Kv4.2
demonstrated mRNA and protein expression levels greater
in the RV than the LV, but with no difference between WT
and Scn5aþ/2 in direct correlation with their peak current
magnitudes. Kv4.3 showed a less clear-cut mRNA expression
pattern, with small increases in WT RV compared with the
remaining groups (in agreement with earlier results), but
showed a similar protein expression pattern to Kv4.2. The dis-
juncture between current magnitudes and mRNA expression
would be consistent with differential KChIP2 expression, in
turn controlling expression of the Ito channel. Our study sup-
ports this hypothesis in showing higher mRNA and protein
expression of KChIP2 in the RV than LV of WT and
Scn5aþ/2 hearts, which could act to increase RV expression
of Kv4.3.
These findings thus directly explain changes in maximum
INa and Ito in terms of altered protein expression. The mech-
anisms of the altered voltage dependence of the Na
þ and K
þ
channel inactivation and K
þ channel current decay particu-
larly in the Scn5aþ/2 RV are unknown, but could possibly
be due to changes in binding to regulatory proteins. For
example, regulation of Nav1.5 is complex, involving inter-
actions with b-subunits and multiple signalling proteins
including cytoskeletal molecules such as ankyrins and syn-
trophins, regulatory kinases and phosphatases, components
of cellular trafficking and extracellular matrix molecules, as
part of large, multi-protein complexes [38]. Thus, in mice,
over-expressing CaMKII, which demonstrates slowed con-
duction and VT, CaMKII-dependent phosphorylation of
Nav1.5 shifts the steady-state inactivation curve towards
negative voltages in a Ca
2þ-dependent manner [39]. Exper-
iments on neonatal rat ventricles and heterologous cells
have demonstrated evidence for functional association of
Ito,f and Nav currents through coupling between Navb1 and
KChIP2, leading to co-regulation in normal circumstances
[40]. It might be possible that disruption to the coupling
mechanism could explain the findings of differential K
þ
channel behaviour in the Scn5aþ/2 hearts. The heterogene-
ities in Ito could thus both modify AP repolarization and also
influence the reduction of Na
þ current in Scn5aþ/2 hearts to
a different extent in the RV than the LV. This could explain
the protective effects of quinidine in reducing the spatial
and temporal electrophysiological heterogeneities and inci-
dence of arrhythmias in BrS [41].
The main limitations of our study come from the differ-
ences between mouse and human hearts in the
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11repolarization phase of the AP, with differences in the range
of K
þ currents displayed. Mouse hearts also use less L-type
Ca
2þ channel current ICa,L, with the mouse cardiac AP lack-
ing a plateau phase. The technical difficulty in separating
epicardial and endocardial layers meant that our study was
limited to a comparison of LV and RV, and we were thus
unable to compare transmural differences. Furthermore, we
acknowledge that the myocyte isolation procedure is
known to cause cell damage, which may affect ionic current
properties, including the number of channels and the peak
conductance; however, our methodology in the perfusion
technique and in the criteria for selection of cells for inclusion
in the study aimed to minimize these factors.
Experimental conditions for Na
þ current measurement
were unphysiological, yet chosen for the following reasons.
First, voltage-clamp control of the cell membrane was con-
sidered. Under physiological conditions, INa is so large and
the kinetics are so rapid that successful voltage-clamp control
is challenging, even in single-cell preparations [42,43]. For
these reasons, we followed protocols that studied INa in a
whole-cell recording configuration under reduced exper-
imental temperatures and lower Na
þ gradients [16,44–46].
As different temperatures were used for INa measurements
from those of IpNa and Ito, direct comparisons of these cur-
rents cannot be made in this paper. Under our conditions,
peak INa was 5.4+0.1 nA and 5.3+0.1 nA for WT LV and
RV, respectively; these values are similar to others under
similar conditions [16,20,47,48]. To enhance voltage-clamp
control, large patch pipettes were used. Thus, peak steady-
state voltage error resulting from residual series resistance
was 2–3 mV, similar to that found in other studies
[16,20,47,49]. If experiments demonstrated evidence of
inadequate voltage control (e.g. a ‘threshold phenomenon’
near the voltage range for Na
þ channel activation), data
were discarded. The absence of crossover of the current
traces as the current magnitude was changed and the shape
of the I–V relationship remaining unchanged for difference
peak current values further suggest adequate voltage control
[16,17]. Only around the reversal potential did we find that
the shape of the I–V relationship differed slightly between
curves, with the WT RV trace giving a slightly more negative
reversal potential than would be expected from the calculated
Nernst potential of þ40 mV. Thus, the clamp voltage was
properly controlled in our dialysed cell experiments, and it
is unlikely that our findings of reduced INa result from
clamp conditions.
The Na
þ flux recorded may have been affected by vol-
tage-dependent blockage by intracellular Mg
2þ, although
this appears to be significant only at high Mg
2þ concen-
trations and for outward currents [50,51]. Ca
2þ flux has also
been postulated to occur through Na
þ channels under b-
adrenergic stimulation in a process dubbed ‘slip-mode
conductance’ [52], although other groups have found
conflicting results [53–55]. While classical studies have
shown little affinity of Ca
2þ or Mg
2þ for the pore site of the
channel [56], the use of low external Na
þ concentrations
may increase possible blockade of the Na
þ channel by
either ion.
While decreased membrane excitability owing to reduced
Na
þ channel function may cause slowed conduction in itself,
there is also growing evidence that it may also lead to con-
duction slowing through the generation of fibrosis [10].
As several previous studies have examined this phenomenon
in the Scn5aþ/2 mouse [2], in this study, we chose to focus
on the possible electrophysiological mechanisms underlying
the arrhythmias; however, we acknowledge the potential
roles of fibrosis in both slowing conduction and also in pro-
moting and maintaining differences in repolarization timing
between myocardial layers. Thus, both structural changes
and differences in ion channel densities and kinetics could
together create optimal pro-arrhythmic conditions.
Changes both in Scn5aþ/2 mice and in BrS patients
could also involve altered expression of a range of other
genes and ion channels. right ventricular outflow tract
(RVOT) origins of arrhythmias might also involve slow con-
ducting tissue whose AP upstroke is ICa,L-dependent [57].
Ventricular mRNA expression profiles in studies of human
BrS associated with Na
þ channelopathy have suggested
remodelled Ca
2þ in addition to Na
þ and K
þ channel
expression [58]. Furthermore, Ca
2þ-dependent mechanisms
are known to play a role in Nav1.5 regulation [59]. Future
work might then explore the possibility that altered current
densities and expression levels of Ca
2þ channels might also
contribute to arrhythmogenesis in Scn5aþ/2 hearts.
The cellular and molecular experiments described
here correlate with work performed in the whole heart,
especially mapping experiments that have localized both
conduction slowing and heterogeneity of repolarization,
and subsequent initiation of arrhythmias through re-
entrant phenomena, to the RV [8]. Computer simulations
could provide a potential means to further explore the
pro-arrhythmic consequences of RV/LV differences in ionic
currents, particularly employing whole heart models
[60–63]. However, this would also entail obtaining further
independent information on detailed conduction pathway
morphology, including extents of fibrosis and cell–cell con-
ductance information in Scn5aþ/2 hearts. While groups
have previously used whole heart models of WT mouse
hearts [60], it has been shown previously that Scn5aþ/2
hearts exhibit heterogeneous fibrosis [2], along with hetero-
geneous expression of connexin 43 and upregulation of
hypertrophic markers including b-MHC and skeletal
a-actin [64].
In conclusion, Scn5aþ/2 mice demonstrate a relative
upregulation of Scn5a expression in the LV compared with
RV. The specifically reduced RV expression of Na
þ channels
leads to smaller INa, resulting in slowed conduction, and
smaller IpNa, which, in combination with increased Ito, results
in shorter AP durations and greater heterogeneity of repolar-
ization, thus suggesting that arrhythmogenesis may be
initiated by both abnormal depolarization and repolarization
in the RV of Scn5aþ/2 hearts.
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